PEB - Pacific Edge Ltd

[Balance]

To be fair DD (foolishly IMO) did mention $100 million of billable tests in 2019, and billable tests only amounted to $14 million.

Yeah 14 million and all done without guidelines or regulatory approval.

Drew95 referred to DD's assertion of US$100m (yes, it was US$100m or NZ$150m) but PEB delivered, get this - NZ$3.8m in the year to March 2019!

NZ$3.8m = 2.5% of said US$100m aimed for in 2019!!!!!! Almost impossible to find another listed company which has failed to achieve its aim by an unimaginable 97.5%!

The $14m referred to by MBJ is the TOTAL sales PEB has generated in 5 years!!!!!!

Any wonder the sp is 21c?

[Minerbarejet]

I think your exclamation mark key is sticking badly.

[davflaws]

How about you guys dial it back a bit. It always gets unpleasant when people start attributing motives to others.

[Dentie]

How about you guys dial it back a bit. It always gets unpleasant when people start attributing motives to others.

You got it mate - I've said my bit!

[RGR367]

......................

................!!!!!!

Any wonder the sp is 21c?

Yeah we were wondering about that too. Shouldn't it be more like 0.021 cents now to really reflect how marvelous (sic) the marketing was carried by this company?

disc: got sucked into this too when it was at 44-50 cents. Got out at 36.

[Drew95]

Drew95 referred to DD's assertion of US$100m (yes, it was US$100m or NZ$150m) but PEB delivered, get this - NZ$3.8m in the year to March 2019!

NZ$3.8m = 2.5% of said US$100m aimed for in 2019!!!!!! Almost impossible to find another listed company which has failed to achieve its aim by an unimaginable 97.5%!

Just to be clear (for those who don't know the full background) that is $NZ 3.8 million as measured by cash in the bank (if US revenue) or cash and receivables if NOT in the US. About 80% of sales are in the US and those sales are not recognized in the books unless and until the cash is banked IE US sales are accounted for on a cash rather than an accrual basis).

Actual Billable sales were around $NZ 14.8 million - around $NZ 11 million could not be recognized as revenue (or receivables) in the financial statements due to NZ Accounting Standards due to NZ IFRS 15. Refer to Note 5, page 28 of the 2019 Financial Statements here...

https://www.pacificedgedx.com/assets...eport-2019.pdf

[Snow Leopard]

Yeah we were wondering about that too. Shouldn't it be more like 0.021 cents now to really reflect how marvelous (sic) the marketing was carried by this company?

disc: got sucked into this too when it was at 44-50 cents. Got out at 36.

A current market cap of $100M for a company with $3.8M operating revenue, a very uncertain future, not to mention the track record of the management (shush!).

At this price it is not even speculating, the risk/reward equation says stay away.


But it would be nice if PEB became a going concern one day.
Disc: Do not hold, no intention to buy.

[Drew95]

Actual Billable sales were around $NZ 14.8 million

Apologies. Should have said - that $14.8 million is not an official number. It is arrived at by multiplying Lab Test (15697 as per the 2019 financial report) by 82% ( as per the 2019 financial report) and then by $NZ 1150 ( the national pricefor all Cxbladder tests (US$760 per test).

[Baa_Baa]

A current market cap of $100M for a company with $3.8M operating revenue, a very uncertain future, not to mention the track record of the management (shush!).

At this price it is not even speculating, the risk/reward equation says stay away.


But it would be nice if PEB became a going concern one day.
Disc: Do not hold, no intention to buy.

Nicely put, might be hard to fathom for some people what many years of shares issuance does to dilute them into oblivion, despite a cap value that stubbornly refuses to acknowledge the company value as a going concern. Maybe one day as you say but even 1/10th of the current SP looks speculative.

One thing Balance has got so right, apart from all the facts, is that this is another unmitigated disaster that the NZX should never have allowed to be listed. No company should ever be listed with just a good idea, some early science, no products, no business model, no customers or revenue. IMHO

CBD anyone? It’s PEB reincarnated.

[Snow Leopard]

....One thing Balance has got so right, apart from all the facts, is that this is another unmitigated disaster that the NZX should never have allowed to be listed. No company should ever be listed with just a good idea, some early science, no products, no business model, no customers or revenue. IMHO....

I totally disagree with you (and thus presumably Balance) on that.

Any company who puts up a reasonable honest prospectus and can find enough financial support should be able to list. [I am sure someone will jump on the word 'honest' there]

It is up to us the potential investors to do our research and decide whether to be involved at the various stages of the companies evolution.